Global Pharmaceuticals & Biotech Breakout Stocks

Arrowhead Pharmaceuticals

Market Cap: US$10.5b

Develops medicines for the treatment of intractable diseases in the United States.

AtaiBeckley

Market Cap: US$2.6b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Harbin Pharmaceutical Group

Market Cap: CN¥15.1b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.

CareDx

Market Cap: US$2.0b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

Xencor

Market Cap: US$1.5b

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.

Forte Biosciences

Market Cap: US$1.2b

Operates as a clinical-stage biopharmaceutical company in the United States.

Cybin

Market Cap: US$502.1m

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders.

Valerio Therapeutics Société anonyme

Market Cap: €390.6m

A clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies.

EI- Nile for Pharmaceuticals and Chemical Industries

Market Cap: ج.م11.8b

Develops, produces, and sells pharmaceutical products in Egypt.

GlaxoSmithKlineE

Market Cap: ج.م10.2b

Engages in production of pharmaceutical chemicals.

Cue Biopharma

Market Cap: US$140.5m

A clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders.

Prescient Therapeutics

Market Cap: AU$82.0m

A clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia.

EOM Pharmaceuticals Holdings

Market Cap: US$16.5m

A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.

Numinus Wellness

Market Cap: US$16.0m

Provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States.

Panacea Life Sciences Holdings

Market Cap: US$7.5m

Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.

Invex Therapeutics

Market Cap: AU$8.6m

A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.

Delex Healthcare Group

Market Cap: US$5.7m

Engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.

Stem Cells Spin

Market Cap: zł21.3m

Operates as a biotechnology company in Poland.

Blueberries Medical

Market Cap: CA$7.4m

A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.

Maple Leaf Green World

Market Cap: US$1.3m

Does not have significant operations.

co.don

Market Cap: €427.6k

Does not have significant operations.

Greater Cannabis Company

Market Cap: US$316.7k

Engages in the development and commercialization of cannabinoid therapeutics.

Myrexis

Market Cap: US$241.4k

Focuses on identifying, evaluating, and making financial investments in life sciences assets.